|
Saddle River, NJ— (April 25, 2006) Facing increasing pressures to successfully manage portfolios and ROI, the industry looked to the 2nd Annual Forum on Early Stage Commercialization Strategies for the Bio/Pharmaceutical Industry to hear distinguished colleagues address best practices. Sponsored by the Center for Business Intelligence, the conference was held April 20-21, 2006 at the Hyatt Regency, Princeton, NJ.
The conference included two pre-conference workshops and a full schedule of sessions geared to:
- Identify systematic approaches for new product planning
- Optimize decision making processes
- Maximize pricing and reimbursement strategies
- Provide best practices for developing commercialization infrastructure
- Highlight resource strategies for new products
In addition, the program addressed pipeline and portfolio management to drive portfolio execution and revenue generation.
PDI, Inc., a diversified sales and marketing services provider to the biopharmaceutical industry, exhibited at the conference to address the issues biopharmaceutical sales and marketing leaders face when commercializing a product. This is consistent with PDI’s mission to fully support emerging companies through the entire commercialization process with sales force infrastructure, medical education, and marketing research solutions.
“By working closely with their service providers during the planning stages, a company can better plan for resource utilization and a successful launch,” states Carl Sailer, VP of Marketing and Business Development for PDI. “This conference was an extraordinary resource for companies to interact with those who are in a position to share successful strategies.”
For more information contact:
Stephen P. Cotugno
Executive Vice President-Corporate Development
PDI, Inc.
201-574-8617
About the Center for Business Intelligence
Founded in 1994 in Boston, CBI Research, Inc. is dedicated to developing market-driven, unbiased conferences in pharmaceuticals\biotech, medical devices, risk and insurance and managed care markets. CBI Research, Inc. offers conferences and summits that serve senior executives and government officials by providing a unique platform for highly focused content and presentation to receive timely information on the latest investment opportunities, business strategies, domestic and international regulatory issues, operations and applied technologies. CBI events provide concrete, real life examples that you can be applied immediately for significant impact on costs and revenue.
About PDI
PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry offering a comprehensive set of outsourced solutions for established and emerging pharmaceutical companies. PDI is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing, and commercialization expertise; and a philosophy of performance.
Headquartered in Saddle River, NJ, PDI’s sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients, and Select Access™, our targeted sales solution that leverages an existing infrastructure. PDI also offers marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM ®) in Dresher, PA. The company’s experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.
PDI’s commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to maintaining the industry’s highest quality employees.
For more information, visit the Company’s website at www.pdi-inc.com.
For more information about PDI’s Performance Sales Teams, visit www.PerformanceSalesTeams.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control.
Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, changes in our operating expenses, adverse patent rulings, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of
any stock repurchase programs, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2004, and PDI's periodic reports on Form 8-K filed with the Securities and Exchange Commission since January 1, 2005. The forward looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
|
